Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

A Translational Approach to Cancer Research, Education and Training.

Ezelle HJ, Geiman T, Schnaper LA, Cullen KJ, Lapidus RS, Hassel BA.

J Cancer Educ. 2020 Jan 6. doi: 10.1007/s13187-019-01675-3. [Epub ahead of print]

PMID:
31907826
2.

The Roles of RNase-L in Antimicrobial Immunity and the Cytoskeleton-Associated Innate Response.

Ezelle HJ, Malathi K, Hassel BA.

Int J Mol Sci. 2016 Jan 8;17(1). pii: E74. doi: 10.3390/ijms17010074. Review.

3.

RNase L interacts with Filamin A to regulate actin dynamics and barrier function for viral entry.

Malathi K, Siddiqui MA, Dayal S, Naji M, Ezelle HJ, Zeng C, Zhou A, Hassel BA.

mBio. 2014 Oct 28;5(6):e02012. doi: 10.1128/mBio.02012-14.

4.

RNase L attenuates mitogen-stimulated gene expression via transcriptional and post-transcriptional mechanisms to limit the proliferative response.

Brennan-Laun SE, Li XL, Ezelle HJ, Venkataraman T, Blackshear PJ, Wilson GM, Hassel BA.

J Biol Chem. 2014 Nov 28;289(48):33629-43. doi: 10.1074/jbc.M114.589556. Epub 2014 Oct 9.

5.

RNase-L control of cellular mRNAs: roles in biologic functions and mechanisms of substrate targeting.

Brennan-Laun SE, Ezelle HJ, Li XL, Hassel BA.

J Interferon Cytokine Res. 2014 Apr;34(4):275-88. doi: 10.1089/jir.2013.0147. Review.

6.

RNase-L deficiency exacerbates experimental colitis and colitis-associated cancer.

Long TM, Chakrabarti A, Ezelle HJ, Brennan-Laun SE, Raufman JP, Polyakova I, Silverman RH, Hassel BA.

Inflamm Bowel Dis. 2013 May;19(6):1295-305. doi: 10.1097/MIB.0b013e318281f2fd.

7.

Regulation of human RNase-L by the miR-29 family reveals a novel oncogenic role in chronic myelogenous leukemia.

Lee TY, Ezelle HJ, Venkataraman T, Lapidus RG, Scheibner KA, Hassel BA.

J Interferon Cytokine Res. 2013 Jan;33(1):34-42. doi: 10.1089/jir.2012.0062. Epub 2012 Oct 31.

8.

Pathologic effects of RNase-L dysregulation in immunity and proliferative control.

Ezelle HJ, Hassel BA.

Front Biosci (Schol Ed). 2012 Jan 1;4:767-86. Review.

9.

A central role for RNA in the induction and biological activities of type 1 interferons.

Li XL, Ezelle HJ, Hsi TY, Hassel BA.

Wiley Interdiscip Rev RNA. 2011 Jan-Feb;2(1):58-78. doi: 10.1002/wrna.32. Epub 2010 Aug 24. Review.

PMID:
21956969
10.

An essential role for the antiviral endoribonuclease, RNase-L, in antibacterial immunity.

Li XL, Ezelle HJ, Kang TJ, Zhang L, Shirey KA, Harro J, Hasday JD, Mohapatra SK, Crasta OR, Vogel SN, Cross AS, Hassel BA.

Proc Natl Acad Sci U S A. 2008 Dec 30;105(52):20816-21. doi: 10.1073/pnas.0807265105. Epub 2008 Dec 15.

11.

Post-transcriptional regulation of RNase-L expression is mediated by the 3'-untranslated region of its mRNA.

Li XL, Andersen JB, Ezelle HJ, Wilson GM, Hassel BA.

J Biol Chem. 2007 Mar 16;282(11):7950-60. Epub 2007 Jan 19.

12.

VSV disrupts the Rae1/mrnp41 mRNA nuclear export pathway.

Faria PA, Chakraborty P, Levay A, Barber GN, Ezelle HJ, Enninga J, Arana C, van Deursen J, Fontoura BM.

Mol Cell. 2005 Jan 7;17(1):93-102.

13.
14.
15.

Hepatitis C virus nonstructural 5A protein induces interleukin-8, leading to partial inhibition of the interferon-induced antiviral response.

Polyak SJ, Khabar KS, Paschal DM, Ezelle HJ, Duverlie G, Barber GN, Levy DE, Mukaida N, Gretch DR.

J Virol. 2001 Jul;75(13):6095-106.

16.

Analyzing the mechanisms of interferon-induced apoptosis using CrmA and hepatitis C virus NS5A.

Ezelle HJ, Balachandran S, Sicheri F, Polyak SJ, Barber GN.

Virology. 2001 Mar 1;281(1):124-37.

Supplemental Content

Loading ...
Support Center